DECREASE OF PROSTATIC INTRAEPITHELIAL NEOPLASIA FOLLOWING ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH STAGE-T3 CARCINOMA TREATED BY RADICAL PROSTATECTOMY

被引:100
作者
FERGUSON, J
ZINCKE, H
ELLISON, E
BERGSTRAHL, E
BOSTWICK, DG
机构
[1] MAYO CLIN & MAYO FDN, DEPT PATHOL, 200 1ST ST SW, ROCHESTER, MN 55905 USA
[2] VANCOUVER GEN HOSP, DEPT PATHOL, VANCOUVER V5Z 1M9, BC, CANADA
[3] MAYO CLIN & MAYO FDN, DEPT UROL, ROCHESTER, MN 55905 USA
[4] MAYO CLIN & MAYO FDN, BIOSTAT SECT, ROCHESTER, MN 55905 USA
关键词
D O I
10.1016/S0090-4295(94)80015-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Prostatic intraepithelial neoplasia (PIN) is considered the most likely precursor of prostatic adenocarcinoma. The effect of androgen deprivation therapy on the prevalence of PIN is unknown. Methods. We undertook a case-control study of radical retropubic prostatectomies from 24 treated patients and a control group of 24 untreated patients matched for age and clinical stage (all T3). Androgen deprivation therapy included LHRH agonist leuprolide and flutamide (18 patients), diethylstilbesterol (DES) (2 patients), DES with leuprolide and flutamide (1 patient), and orchiectomy (3 patients). Prostatectomy specimens were evaluated for the presence and extent of high-grade PIN according to the number of high-power microscopic fields, and nuclear tumor grade (1 to 4 scale) and Gleason score were also determined. Results. The prevalence of high-grade PIN in pretreatment transrectal needle biopsies was similar in the treated and untreated groups. The prevalence and extent of high-grade PIN were lower in cases treated with androgen deprivation therapy than controls. Nuclear tumor grade was also lower in treated patients, but there was a paradoxical increase in the Gleason score. The prevalence of aneuploidy in the cancers was similar in both groups. Conclusions. These findings suggest that androgen deprivation therapy decreases the prevalence and extent of high-grade PIN.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 31 条
  • [1] SQUAMOUS METAPLASIA OF PROSTATE FOLLOWING ESTROGEN THERAPY
    BAINBOROUGH, AR
    [J]. JOURNAL OF UROLOGY, 1952, 68 (01) : 329 - 336
  • [2] BOSTWICK DG, 1987, CANCER, V59, P788, DOI 10.1002/1097-0142(19870215)59:4<788::AID-CNCR2820590421>3.0.CO
  • [3] 2-I
  • [4] BOSTWICK DG, 1992, J CELL BIOCHEM, P10
  • [5] COLOMBEL M, 1993, AM J PATHOL, V143, P390
  • [6] DENIS L, 1991, UROL CLIN N AM, V18, P65
  • [7] ANDROGEN ACTION BLOCKADE DOES NOT RESULT IN REDUCTION IN SIZE BUT CHANGES HISTOLOGY OF THE NORMAL HUMAN-PROSTATE
    DEVOOGT, HJ
    RAO, BR
    GELDOF, AA
    GOOREN, LJG
    BOUMAN, FG
    [J]. PROSTATE, 1987, 11 (04) : 305 - 311
  • [8] ELLSION E, UNPUB NUCLEOLUS POOR
  • [9] FLAMM J, 1991, EUR UROL, V19, P192
  • [10] GORMLEY GJ, 1992, J CELL BIOCHEM, P113